• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Innova Captab Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 74713.0
  • ISIN : INE0DUT01020
878.45 10 (1.20%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    860.10

  • Today’s High

    881.50

  • Open

    860.10

  • Perv Close

    868.05

  • 52W Low

    421.35

  • 52W High

    1,260.00

Key Indicators

  • P/E(TTM)

    56.08

  • Mar.Cap (₹Cr.)

    5,026.92

  • Div & Yield %

    0.00

  • Book Value(₹)

    142.06

  • Debt-Equity Ratio

    1.20

  • AGM Date

    30-May-2025

  • EPS

    15.63

  • P/E Ratio

    56.08

Financials Ratios

  • Debt-Equity Ratio

    0.38

  • Mar.Cap (₹Cr.)

    5,026.92

  • RONW (%)

    17.04

  • ROCE (%)

    18.76

Score Board

  • Equity (₹ in Cr.)

    57.22

  • BV (₹)

    142.10

  • Sales( ₹ in Cr.)

    958.06

  • NP (in Cr.)

    89.47

  • NP Var(%)

    29.0

  • Div%

    0.0

  • CPS (₹)

    18.60

  • EPS (₹)

    15.60

  • Traded Value (₹ in Lakhs)

    5,016.34

  • 52 Week High

    1,260.00

  • 52 Week Low

    421.35

  • Price BSE

    877.0

  • Price NSE

    878.00

  • Market Capital( in Cr.)

    5,016.34

  • P/C Ratio

    47.10

  • P/E Ratio

    56.10

  • Price Vs.BV

    15.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 864.93 858.67 785.46 410.66 373.32 -
Excise Duty 0.00 0.00 0.00 0.00 0.00 -
Net Sales 864.93 858.67 785.46 410.66 373.32 -
Other Income 10.72 8.73 2.86 1.37 1.30 -
Stock Adjustments 1.35 1.48 -1.00 -1.64 7.76 -
Total Income 877.00 868.88 787.32 410.39 382.38 -
EXPENDITURE :            
Raw Materials 506.91 529.83 607.88 309.06 291.55 -
Power and Fuel Cost 11.58 9.42 7.90 5.48 5.54 -
Employee Cost 50.11 43.60 36.30 22.22 20.24 -
Other Manufacturing Expenses 163.40 157.91 11.67 5.25 4.30 -
Selling and Administration Expenses 19.77 17.66 16.63 9.57 7.61 -
Miscellaneous Expenses 6.54 3.21 5.57 2.96 0.91 -
Employee Benefit Expenses 50.11 43.60 36.30 22.22 20.24 -
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 -
Total Expenses 758.31 761.63 685.95 354.54 330.15 -
Operating Profit 118.69 107.26 101.37 55.86 52.24 -
Interest 13.59 18.30 5.33 3.93 4.63 -
Gross Profit 105.10 88.96 96.04 51.93 47.61 -
Depreciation 11.40 10.66 7.40 5.59 10.08 -
Profit Before Tax 93.70 78.30 88.64 46.34 37.53 -
Current Tax 25.18 18.86 21.80 11.50 9.25 -
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 -
Deferred Tax 0.35 1.89 0.66 0.35 0.40 -
Reported Net Profit 68.16 57.55 66.18 34.50 27.89 -
Extraordinary Items -1.38 1.66 -0.01 0.11 0.00 -
Adjusted Net Profit 69.54 55.89 66.19 34.39 27.89 -
Adjustment below Net Profit 0.28 -36.06 -0.17 -0.08 -0.02 -
P & L Balance brought forward 220.28 198.78 132.78 98.35 70.49 -
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 -
Appropriations 0.00 0.00 0.00 0.00 0.00 -
P & L Balance carried down 288.71 220.28 198.78 132.78 98.35 -
Dividend 0.00 0.00 0.00 0.00 0.00 -
Preference Dividend 0.00 0.00 0.00 0.00 0.00 -
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 -
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 -
Earnings Per Share-Unit Curr 11.91 11.99 55.15 287.50 232.38 -
Earnings Per Share(Adj)-Unit Curr 11.91 - - - - -
Book Value 126.47 55.90 175.69 1,206.84 919.62 -
Book Value(Adj)-Unit Curr 126.47 - - - - -

Shareholding Pattern

  • Promoter Group

    50.90%

  • Public Share Holding

    49.10%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 29,127,321 50.90 29,127,321 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 29,127,321 50.90 29,127,321 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 196,025 0.34 196,025 15
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 1,039,717 1.82 1,039,717 1
Mutual Funds / UTI 6,151,890 10.75 6,151,890 9
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 4,117,891 7.20 4,117,891 8
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 11,505,523 20.11 11,505,523 33
2] Non Institution
Bodies Corporate 546,484 0.96 546,484 232
Clearing Members 579 0.00 579 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 111,971 0.20 111,971 509
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 125,167 0.22 125,167 932
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 12,812,022 22.39 12,812,022 8
Individuals holding nominal share capital up to Rs. 1 lakh 2,995,862 5.24 2,995,862 38,276
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 16,592,085 28.99 16,592,085 39,959
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 57,224,929 100.00 57,224,929 39,996

Company Background

Innova Captab LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Innova Captab Ltd
  • BSE Code : 74713.0
  • ISIN : INE0DUT01020

  • Incorporation Year

    2005

  • Registered Office

    601 Proxima Plot # 19
    Sector 30 A Vashi, Navi Mumbai,
    Maharashtra-400705

  • Telephone

    91-22-2564 2095

  • FAX

  • Chairman

    MANOJ KUMAR LOHARIWALA

  • Managing Director

    VINAY KUMAR LOHARIWALA

  • Company Secretary

    Neeharika Shukla

  • Auditor

    BSR & Co LLP

  • Face Value

    10

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Innova Captab Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Innova Captab 876.60 875.65 864.93 56.08 14.44
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92